Cargando...
Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
BACKGROUND: Monitoring circulating tumor cells (CTC) has been shown to be prognostic in most solid malignancies. There is no CTC assay in clinical use for lung cancer therapy monitoring due to inconclusive clinical utility data. Limited data has been published outside of the standard CTC enumeration...
Gardado en:
| Publicado en: | J Transl Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714097/ https://ncbi.nlm.nih.gov/pubmed/31462312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-2035-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|